Skip to main content
. 2020 Jan 7;11(1):31–45. doi: 10.18632/oncotarget.27414

Figure 3. Reactivity of anti-HER3 mAb with various human cell lines.

Figure 3

Reactivity of anti-HER3 mAb (Ab4) with human various normal, non-cancer and cancer cell lines was analyzed by FCM, and mAb binding was shown by ΔMFI.